CBSCBS News·1hHealth
score-0.70
CBS News Investigation Prompts Renewed FDA Oversight Focus on Unapproved Weight Loss Drug Retatrutide as Clinical Trials Continue
Original
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
“Alarming framing emphasizes FDA non-approval, off-label prescribing, and serious side effects risks without balancing context.”